ARL

Arvind Remedies Limited has informed the Exchange regarding the Outcome of the Board of Directors of the Company at its meeting held on February 11, 2012.

Arvind Remedies Limited has informed the Exchange that in the Meeting of Board of Directors of the Company held on August 02, 2011, following items were considered : 1) Board approved the proposal to acquire an existing manufacturing company engaged in a similar line of business at an overall consideration of Rs. 11 Crores. 2) The notice convening the Annual General Meeting was approved and it was decided to include the following items as special business i) Conversion of the preference share capital into the equity share capital . ii) Amendment of the existing Articles of Association of the C

Arvind Remedies Limited has informed the Exchange that in the Meeting of Board of Directors of the Company held on January 5, 2011, the Board approved allotment of 22,22,50,000 equity shares issued on preferential basis, to Dr. Arvind Kumar B Shah HUF, M/s. Narit Tradecom Pvt Ltd. and M/s. Aryaman Commerce P Ltd. from whom the company has received the consideration @ Re. 1.00 each with premium of Rs. 1.25 per share.

Arvind Remedies Limited has informed the Exchange regarding the outcome of the Board Meeting held on September 07, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/arvind_outcome_10092009.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2009 the Board discussed that : (a) due to changes in the fiscal policies, the benefits available on the Hardiwar unit have been substantially reduced and hence not to pursue with the project. (b) For the proposed new project near Chennai, the project feasibility report be obtained and placed in the next Board meeting for decision. The funding of the project will also be discussed in that meeting. Resultantly, the proposed resolutions u/s 94 for increasing authorized shar

Arvind Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on March 28, 2009, considered the Preferential Issue of equity shares to Dr. Arvind Kumar B Shah (HUF) on conversion of the unsecured loan given by him into equity. While taking this decision it was felt that based on the application to SEBI for giving in-principal approval, it may await for the same as the promoter has already submitted necessary application for exemption from SEBI (SAST) Regulations, 1997 which was pending before SEBI. Accordingly, subject to the approval by SEBI, it was dec

Arvind Remedies Limited has informed the Exchange that Due to unavoidable reasons Company is withdrawing the earlier intimation regarding the Meeting of the Board of Directors of the Company to be held on December 31, 2007.

Arvind Remedies Limited has informed the Exchange that the Board of Directors in their meeting held on March 09, 2006 had decided to set up a new manufacturing unit at Haridwar, in the State of Uttaranchal, at par with the international standards.

Arvind Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on February 27, 2006 had considered and approved the following :- (a) To increase the paid up capital by issue and allot 1,34,00,000 Equity Shares of Re.1/- each at a price of Rs.2.40 (Including premium) to Dr. B. Arvind Shah. (b) To issue and allot 1,40,90,000 warrants to Dr. B. Arvind Shah having rights to convert upto 1,40,90,000/- equity shares of Re.1/- each at a price of Rs.2.40 (including premium). (c) To hold an EGM of the shareholders on March 27, 2006 to get the shareholder's approval